inhibit eukaryotic type IIA topoisomerases and are there-
fore widely used in cancer chemotherapy. Indeed, ⬃50% of
cancer chemotherapy regimens contain at least one drug
targeted to type IIA topoisomerases.
Type IIA topoisomerase inhibitors act in either of two
ways. Many of them, including novobiocin, inhibit their tar-
get enzyme’s ATPase activity (novobiocin is a competitive
inhibitor of ATP because it tightly binds to GyrB in a way
that prevents the binding of ATP’s adenine ring). They
therefore kill cells by blocking topoisomerase activity,
which results in the arrest of DNA replication and RNA
transcription. However, other substances, including
ciprofloxacin, doxorubicin, and etoposide,enhance the rate
at which their target type IIA topoisomerases cleave
double-stranded DNA and/or reduce the rate at which
these enzymes reseal these breaks. Consequently, these
agents induce higher than normal levels of transient
protein-bridged breaks in the DNA of treated cells. These
protein bridges are easily ruptured by the passage of the
replication and transcription machinery, thereby rendering
the breaks permanent. Although all cells have elaborate
enzymatic systems to repair damaged DNA (Section 30-5),
a sufficiently high level of DNA damage overwhelms these
systems and hence results in cell death. Consequently, since
rapidly replicating cells such as cancer cells have elevated
levels of type IIA topoisomerases, they are far more likely
to incur lethal DNA damage through the poisoning of their
type IIA topoisomerases than are slow-growing or quies-
cent cells.
Type IB topoisomerases are specifically inhibited by the
quinoline-based alkaloid camptothecin
(a product of the Chinese yew tree, Camptotheca acumi-
nata) and its derivatives, which act by stabilizing the cova-
lent topoisomerase I–DNA complex. These compounds,
the only known naturally occurring topoisomerase IB in-
hibitors, are potent anticancer agents.
OH
N
NO
O
Camptothecin
CH
2
O
CH
3
1170 Chapter 29. Nucleic Acid Structures
1 Double Helical Structures B-DNA consists of a right-
handed double helix of antiparallel sugar–phosphate chains
with ⬃10 bp per turn of 34 Å and with its bases nearly perpen-
dicular to the helix axis. Bases on opposite strands hydrogen-
bond in a geometrically complementary manner to form A ⴢ T
and G ⴢ C Watson–Crick base pairs. At low humidity, B-DNA
undergoes a reversible transformation to a wider, flatter right-
handed double helix known as A-DNA. Z-DNA, which is
formed at high salt concentrations by polynucleotides of alter-
nating purine and pyrimidine base sequences, is a left-handed
double helix. Double helical RNA and RNA ⴢ DNA hybrids
have A-DNA-like structures. The conformation of DNA, par-
ticularly that of B-DNA, varies with its base sequence largely
because DNA’s flexibility varies with its base sequence.
2 Forces Stabilizing Nucleic Acid Structures The orien-
tations about the glycosidic bond and the various torsion an-
gles in the sugar–phosphate chain are sterically constrained in
nucleic acids. Likewise, only a few of the possible sugar pucker
conformations are commonly observed. Watson–Crick base
pairing is both geometrically and electronically complemen-
tary. Yet hydrogen bonding interactions do not greatly stabi-
lize nucleic acid structures. Rather, the structures are largely
stabilized by hydrophobic interactions. Nevertheless, the hy-
drophobic forces in nucleic acids are qualitatively different in
character from those that stabilize proteins. Electrostatic in-
teractions between charged phosphate groups are also impor-
tant structural determinants of nucleic acids.
CHAPTER SUMMARY
3 Supercoiled DNA The linking number (L) of a cova-
lently closed circular DNA is topologically invariant. Conse-
quently, any change in the twist (T) of a circular duplex must
be balanced by an equal and opposite change in its writhing
number (W), which indicates its degree of supercoiling.Super-
coiling can be induced by intercalation agents. The gel elec-
trophoretic mobility of DNA increases with its degree of su-
perhelicity. Naturally occurring DNAs are all negatively
supercoiled and must be so in order to participate in DNA
replication and RNA transcription.
Type IA topoisomerases relax negatively supercoiled
DNAs via a strand passage mechanism in which they cleave a
single strand of DNA to form a 5¿-phosphoTyr bond, pass a
single-strand DNA segment through the gap, and then reseal
the gap. Type IB topoisomerases relax both negatively and
positively supercoiled DNAs via a controlled rotation mecha-
nism involving a single-strand cleavage in which a transient
phosphoTyr bond is formed with the newly generated 3¿ end.
Type II topoisomerases relax duplex DNA in increments of
two supertwists at the expense of ATP hydrolysis by making a
double-strand scission in the DNA so as to form two transient
5¿-phosphoTyr linkages, passing the duplex through the break,
and resealing it. DNA gyrase also generates negative super-
twists in an ATP-dependent manner. Topoisomerases are the
targets of several antibiotics and chemotherapeutic agents.
JWCL281_c29_1143-1172.qxd 8/2/10 8:06 PM Page 1170